8-K - Beam Therapeutics Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Financial Results

Financing

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On February 24, 2026 (the “Closing Date”), Beam Therapeutics Inc. (the “Company”) entered into a financing agreement

Material Agreement

$500.0M$100.0M$100.0M$100.0M

2.02

as well as in the accompanying Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exch

Financial Results

2.03

. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release Issued by Beam Therapeutics Inc. on February 24, 2026 104

Financing

Exhibits (2)

8-K

99.1

EX-99.1